https://scholars.lib.ntu.edu.tw/handle/123456789/511226
標題: | Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia | 作者: | HSIN-AN HOU TIFFANY TING-FANG SHIH Liu C.-Y. BANG-BIN CHEN JIH-LUH TANG MING YAO SHANG-YI HUANG WEN-CHIEN CHOU CHAO-YU HSU HWEI-FANG TIEN |
公開日期: | 2010 | 卷: | 95 | 期: | 8 | 起(迄)頁: | 1420-1424 | 來源出版物: | Haematologica | 摘要: | Recently, dynamic contrast-enhanced magnetic resonance imaging has been shown to be a on-invasive technique that provides global and functional imaging of bone marrow angiogenesis in acute myeloid leukemia. To assess the clinical implication of changes in angiogenesis shortly after induction chemotherapy, dynamic contrastenhanced magnetic resonance imaging was performed prospectively before treatment (day 0) and on day 7 in 80 patients with de novo acute myeloid leukemia. We demonstrated that a post-therapeutic reduction in Peak (negative ΔPeak) compared with the day 0 value was significantly associated with a higher chance of achieving complete remission, and better overall and disease free survival (P=0.022, 0.003 and 0.007, respectively). Cox's multivariate analysis also identified negative ΔPeak value as an independent good prognostic factor for overall and disease free survival. Our findings provide evidence that the change of Peak on day 7 relative to pre-treatment levels may be a relevant biomarker for early identification of patients who may fail conventional induction chemotherapy ClinicalTrials.gov Identifier: NCT00172562).? 2010 Ferrata Storti Foundation. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/511226 | ISSN: | 0390-6078 | DOI: | 10.3324/haematol.2009.019364 | SDG/關鍵字: | anthracycline; cytarabine; gadolinium pentetate meglumine; idarubicin; acute granulocytic leukemia; adolescent; adult; aged; article; bone marrow disease; cancer chemotherapy; clinical trial; contrast enhancement; controlled clinical trial; controlled study; disease free survival; drug efficacy; drug megadose; female; high risk patient; human; image analysis; leukemia remission; major clinical study; male; nuclear magnetic resonance imaging; outcome assessment; overall survival; prognosis; treatment response; tumor vascularization; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Time Factors; Treatment Outcome; Young Adult |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。